Drugs / K301
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01137331 | Feb → Apr 2008 | seborrheic dermatitis | Moberg Pharma AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | K301 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01137331 ↗ |
| Route | Topical | “K301 applied topically to the affected area of the scalp once daily during the 4 weeks.” NCT01137331 ↗ |